Cargando…
Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
OBJECTIVES: To compare the net clinical benefit of oral anticoagulant (OAC) monotherapy to OAC plus single antiplatelet therapy (SAPT) in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) at 1- and 3-year after percutaneous coronary intervention (PCI). BACKGROUND: It ha...
Autores principales: | Lee, So-Ryoung, Jung, Jin-Hyung, Choi, Eue-Keun, Lee, Seung-Woo, Kwon, Soonil, Park, Ji-Suck, Kang, Jeehoon, Han, Kyung-Do, Park, Kyung Woo, Oh, Seil, Lip, Gregory Y. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441665/ https://www.ncbi.nlm.nih.gov/pubmed/36072876 http://dx.doi.org/10.3389/fcvm.2022.991293 |
Ejemplares similares
-
Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2022) -
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Kwon, Soonil, et al.
Publicado: (2021) -
Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study
por: Park, Jiesuck, et al.
Publicado: (2021) -
Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2020) -
Impact of components of metabolic syndrome on the risk of adverse renal outcomes in patients with atrial fibrillation: a nationwide cohort study
por: Kwon, Soonil, et al.
Publicado: (2023)